Article info

Download PDFPDF

Research paper
Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis

Authors

  1. Correspondence to Professor Peter J Goadsby, Wellcome Foundation Building, King’s College Hospital, London SE5 9PJ, UK; peter.goadsby{at}kcl.ac.uk
View Full Text

Citation

Goadsby PJ, Dodick DW, Martinez JM, et al
Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis

Publication history

  • Received December 19, 2018
  • Revised March 5, 2019
  • Accepted March 18, 2019
  • First published April 19, 2019.
Online issue publication 
July 11, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.